Physician profile
David Mitchell
NPI 1912908658
$5,368.79
in general payments reported to CMS, 2019-2025
21 companies · $926 in 2025
The $926 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $257 · 2021: $294 · 2022: $983 · 2023: $1,009 · 2024: $1,335 · 2025: $926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,269.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $888.56 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $628.84 | 2022-2025 | Miebo, Xiidra, Infuse |
| Oyster Point Pharma, INC. | $615.95 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Alcon Vision LLC | $592.30 | 2019-2025 | Hydrus Microstent, Total30, Precision 1 |
| Novartis Pharmaceuticals Corporation | $404.81 | 2019-2023 | |
| Abbvie INC. | $383.77 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $344.54 | 2019-2025 | Cequa |
| Dompe US, INC. | $336.27 | 2022-2025 | Oxervate |
| Harrow Eye, LLC | $332.18 | 2024-2025 | Vevye |
| Shire North American Group INC | $222.59 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $177.32 | 2024-2025 | Xdemvy |
| Coopervision INC. | $72.58 | 2022-2024 | Myday Contact Lens |
| Biotissue Holdings INC. | $65.50 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $65.49 | 2019-2020 | |
| Allergan, INC. | $53.31 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $45.99 | 2020 | |
| Abb Con-Cise Optical Group LLC | $44.37 | 2019 | |
| Eyevance Pharmaceuticals LLC | $34.33 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $24.45 | 2023 | Acthar |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Thea Pharma INC. | $16.24 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.